Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).
Rossini S.à r.l. plans to sell about 10.5 million ordinary shares of Recordati, equating to 5% of the company’s share capital, through an accelerated bookbuilding process targeting institutional and qualified investors. This placement will aid Rossini in fulfilling its finance obligations, including debt repayment and shareholder distributions, but Recordati itself will not benefit financially from this sale.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. operates in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceuticals for primary care and specialty markets.
YTD Price Performance: 18.08%
Average Trading Volume: 25,998
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €12.33B
For a thorough assessment of REC stock, go to TipRanks’ Stock Analysis page.
